Skip to content
AiScope logo — We develop open-source technologies for a improved diagnosis...

AiScope

We develop open-source technologies for a improved diagnosis of infectious diseases

Founded 2017 Spain Spain 5 employees AI, Health Care

General Information

Company Name AiScope
Founded Year 2017
Location Spain Spain
Employees 5
Industries AI, Health Care
Social

BounceWatch is an independent company data service, not affiliated with AiScope. To contact AiScope, visit aiscope.net.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does AiScope compare?

A PDF of AiScope and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting AiScope soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About AiScope

AiScope is a Spanish-based startup with a mission to revolutionize infectious disease diagnosis using open-source technologies. The company's slogan - "We develop open-source technologies for an improved diagnosis of infectious diseases" perfectly encapsulates their vision to leverage technology for societal impact. By focusing on diseases like malaria, tuberculosis, and diarrhea, AiScope aims to address the pressing need for timely detection and treatment in low- and middle-income countries.

Founded in 2017, AiScope consists of a diverse team committed to leveraging AI and healthcare expertise to develop innovative solutions. Their flagship project, the AI Scope, is a non-profit, open-source smart microscope designed to enhance disease diagnosis using AI, particularly in resource-constrained and remote communities.

A distinctive aspect of AiScope is its emphasis on community involvement, as the company welcomes collaboration with individuals and organizations who share their passion for utilizing technology to improve public health. Although specific investment details are currently unavailable, AiScope's commitment to utilizing technological innovation for social good positions it as an intriguing prospect for potential investors seeking impactful opportunities.

Business keywords: MedTech, Malaria, Tuberculosis, Infectious Diseases, Microscope, Open-source Technology, Computer-aided Diagnosis

No funding data available for AiScope yet.

AiScope Alternatives & Competitors

View All Alternatives
AiScope vs
QMIRA
QMIRA United States

Providing affordable diagnostic solutions for infectious and parasitic diseases with AI-enhanced mic...

Pre-Seed
2 employees
AI, Biopharma
AiScope vs

Developing advanced AI tools to enhance early detection of brain degenerative diseases and optimize...

Seed
AI, Health Care
AiScope vs

Automated sampling of pathogens for improved global health security

9 employees
AI, Automation

FAQ About AiScope

We develop open-source technologies for a improved diagnosis of infectious diseases
AiScope was founded in 2017.
AiScope is headquartered in Spain.
AiScope operates in AI and Health Care. Its work centres on MedTech, Malaria, Tuberculosis and Infectious Diseases.
AiScope has approximately 5 employees.
Top alternatives and competitors to AiScope include QMIRA, Avalon AI, Lifeline Robotics, Deep Bio Inc., Legit.Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AiScope and QMIRA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for AiScope, https://bouncewatch.com/company/aiscope, updated 6 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout